Two classes of 5-substituted benzimidazoles were identified as potent antagonists of the NR2B subtype of the N-methyl-d-aspartate (NMDA) receptor. Selected compounds show very good selectivity versus the NR2A, NR2C, and NR2D subtypes of the NMDA receptor as well as versus hERG-channel activity and alpha(1)-adrenergic binding. Benzimidazole 37a shows excellent activity in the carrageenan-induced mechanical hyperalgesia assay in rats as well as good pharmacokinetic behavior in dogs.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm030483sDOI Listing

Publication Analysis

Top Keywords

5-substituted benzimidazoles
8
nmda receptor
8
nr2b-selective n-methyl-d-aspartate
4
n-methyl-d-aspartate antagonists
4
antagonists synthesis
4
synthesis evaluation
4
evaluation 5-substituted
4
benzimidazoles classes
4
classes 5-substituted
4
benzimidazoles identified
4

Similar Publications

Article Synopsis
  • The study focused on developing new compounds targeted at activating the SIRT1 enzyme, which plays a role in managing metabolic disorders.
  • Researchers used molecular docking and dynamics to assess how well these compounds interacted with SIRT1, synthesizing those with strong binding affinity.
  • Among the compounds tested, one (5m) showed the most promise for activation, with strong efficacy and favorable drug-like properties, suggesting potential for future research in animal models.
View Article and Find Full Text PDF

Novel hydroxy- and amidino-substituted benzimidazoles and benzothiazoles as antibacterial and antiproliferative agents.

Future Med Chem

July 2023

Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, HR-10000, Croatia.

The aim was synthesis of novel benzazoles bearing amidino and 2-hydroxyphenyl substituents to explore their biological activity. Condensation of 5-substituted salicylaldehydes and intermediates gave new benzazoles by previously published and developed procedures, which were tested for antibacterial and antiproliferative activity . The best antibacterial activity showed benzimidazole with 2-imidazolinyl group and benzothiazole with an unsubstituted amidine (minimum inhibitory concentration 8 μg/ml).

View Article and Find Full Text PDF

Microtubule targeting agents (MTAs) are the potential drug candidates for anticancer drug discovery. Disrupting the microtubule formation or inhibiting the de-polymerization process by a synthetic molecule can lead to an excellent anticancer drug candidate. Here, we present the 2,5-substituted-1H-benzo[d]imidazole derivatives as potential colchicine, nocodazole binding site targeting agents.

View Article and Find Full Text PDF

FtsZ inhibitors as a new genera of antibacterial agents.

Bioorg Chem

October 2019

University Department of Pharmaceutical Sciences, Utkal University, Vani Vihar, Bhubaneswar 751004, Odisha, India.

The continuous emergence and rapid spread of a multidrug-resistant strain of bacterial pathogens have demanded the discovery and development of new antibacterial agents. A highly conserved prokaryotic cell division protein FtsZ is considered as a promising target by inhibiting bacterial cytokinesis. Inhibition of FtsZ assembly restrains the cell-division complex known as divisome, which results in filamentation, leading to lysis of the cell.

View Article and Find Full Text PDF

Owing to the growing need for antifungal agents, we synthesized a new series 2-((5-(4-(5-substituted-1-benzimidazol-2-yl)phenyl)-4-substituted-4-1,2,4-triazol-3-yl)thio)-1-(substitutedphenyl)ethan-1-one derivatives, which were tested against species. The synthesized compounds were characterized and elucidated by FT-IR, ¹H-NMR, C-NMR and HR-MS spectroscopies. The synthesized compounds were screened in vitro anticandidal activity against species by broth microdiluation methods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!